KING LUTHER CAPITAL MANAGEMENT CORP 13D and 13G filings for scPharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-28 10:56 am Purchase |
2024-12-31 | 13G | scPharmaceuticals Inc. SCPH |
KING LUTHER CAPITAL MANAGEMENT CORP | 2,980,410 6.000% |
95,730 (+3.32%) |
Filing |
| 2024-11-15 4:06 pm Purchase |
2024-11-14 | 13G | scPharmaceuticals Inc. SCPH |
KING LUTHER CAPITAL MANAGEMENT CORP | 2,884,680 5.800% |
561,390 (+24.16%) |
Filing |
| 2024-10-30 4:05 pm Purchase |
2024-09-30 | 13G | scPharmaceuticals Inc. SCPH |
KING LUTHER CAPITAL MANAGEMENT CORP | 2,323,290 4.600% |
22,400 (+0.97%) |
Filing |
| 2024-07-02 4:06 pm Purchase |
2024-06-30 | 13G | scPharmaceuticals Inc. SCPH |
KING LUTHER CAPITAL MANAGEMENT CORP | 2,300,890 6.400% |
404,301 (+21.32%) |
Filing |
| 2024-05-20 4:05 pm Purchase |
2024-05-17 | 13G | scPharmaceuticals Inc. SCPH |
KING LUTHER CAPITAL MANAGEMENT CORP | 1,896,589 5.300% |
1,896,589 (New Position) |
Filing |